SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Algorand is a scalable, secure, and decentralized digital currency and smart contract platform. Its protocol uses a variation of Proof-of-Stake (PoS) called Pure PoS (PPoS) to secure the network and reach consensus on block production. Developers can build decentralized applications (dApps) using familiar programming languages, including Python, which Algorand supports natively. Its infrastructure enables various use cases, including payment systems, digital identity solutions, supply-chain tracking, and financial services. The protocol's architecture allows for tokenization of assets and the development of smart contracts, while its technical specifications support both retail users seeking basic transaction capabilities and enterprises requiring more, complex, blockchain solutions.

Algorand

Algorand is currently trending due to a surge in social dominance and trading volume, driven by renewed interest in its quantum-resistant technology and strategic positioning in the US market. The community is actively discussing the coin's perceived undervaluation, potential for a long-term breakout, and recent network activity, with many retail investors debating the timing of a reversal from recent lows.

Uniting the six native Japanese dog breeds. Kendu is the keeper of peace, the preserver of life, and the protector of unity. Join the pack!!

Kendu

Kendu is generating intense community engagement as holders focus on its identity as a permissionless brand that incentivizes real-world product development and grassroots marketing. Supporters are actively showcasing their conviction by organizing in-person events and launching diverse initiatives, positioning the project as a long-term, community-driven play.

Amprius Technologies, Inc. engages in the development, manufacture, and market of lithium-ion batteries for mobility applications, including the aviation, electric vehicle and light electric vehicle industries. It operates through the following geographical segments: North America, EMEA, and Asia Pacific. The company was founded by Mark C. Platshon in 2008 and headquartered in Fremont, CA.

Amprius Technologies Inc

Amprius Technologies is trending as investors react to strong quarterly earnings, where the company reported significant year-over-year revenue growth and increased its 2026 revenue guidance. The community is actively discussing the company's expanding customer base and potential for long-term growth as a key battery supplier within the drone and defense sectors, while also debating the stock's volatility and the impact of upcoming warrant triggers.

Marvell Technology, Inc. engages in the design, development, and sale of integrated circuits. Its products include data processing units, security solutions, automotive, coherent DSP, DCI optical modules, ethernet controllers, ethernet PHYs, ethernet switches, linear driver, PAM DSP, transimpedance amplifiers, fibre channel, HDD, SSD controller, storage accelerators, ASIC, and Marvell government solutions. It operates through the following geographical segments: United States, Singapore, Israel, India, China, and Others. The company was founded by Wei Li Dai and Pantas Sutardja in 1995 and is headquartered in Wilmington, DE.

Marvell Technology Inc

Marvell Technology is currently seeing heavy trading volume and heightened investor interest following a partnership announcement with NVIDIA, which includes a multi-billion dollar strategic investment aimed at scaling AI infrastructure. While bullish participants point to the company's central role in the AI supply chain and potential for sustained revenue growth, others are closely watching key technical resistance levels around the $100 mark and navigating significant volatility driven by options flow and broader market uncertainty.

Syndax Pharmaceuticals, Inc. engages in the development of cancer therapies. Its products include SyndAccess, Revuforj, Niktimvo, and IncyteCARES. The company was founded by Richard A. Heyman, Eckard Weber, Peter Ordentlich, Ronald M. Evans and Michael Downes on October 11, 2005 and is headquartered in New York, NY.

Syndax Pharmaceuticals Inc

Syndax Pharmaceuticals is trending as the community speculates on a potential buyout, particularly by Incyte, driven by the strong commercial trajectory of its FDA-approved drugs Revuforj and Niktimvo. Investors are closely watching for clinical data updates at the upcoming ASH meeting, with many debating the competitive landscape versus Kura Oncology while viewing the stock as significantly undervalued relative to its oncology peers.

NIO, Inc. is a holding company which engages in the design, manufacture, and sale of electric vehicles. Its products include the EP9 supercar and ES8 7-seater SUV. It provides users with home charging, power express valet services, and other power solutions including access to public charging, access to power mobile charging trucks, and battery swapping. It also offers other value-added services such as service package, battery payment arrangement, and vehicle financing and license plate registration. The company was founded by Bin Li and Li Hong Qin on November 28, 2014 and is headquartered in Jiading, China.

NIO Inc - ADR

NIO Inc

NIO is trending following a massive surge in March delivery numbers that significantly beat growth expectations, fueling strong community excitement for potential profitability. Investors are actively discussing the company's multi-brand expansion and the potential for a short squeeze as the stock continues to test key resistance levels.

Abacus Global Management, Inc. is a pioneering alternative asset manager specializing in uncorrelated financial products that leverage proprietary longevity data and actuarial technology. It operates through the following business segments: Asset Management, Life Solutions and Technology Services. The Asset Management segment provides asset management services primarily to institutional investors, as well as private clients, investing in uncorrelated longevity-based assets, fixed-income replacement strategies, and free cash flow–based investment solutions. The Life Solutions segment is engaged in the buying, selling, and trading of policies, as well as maintaining policies until the receipt of death benefits. The Technology Services segment provides real-time mortality verification, missing participant verification, and other life insurance–specific services to customers on a contract basis. The company was founded by Matthew Ganovsky, Kevin Scott Kirby, and Todd Sean McNealy in 2004 and is headquartered in Orlando, FL.

Abacus Global Management Inc. - Ordinary Shares - Class A

Abacus Global Management is capturing investor attention as its vertical integration strategy, highlighted by a major strategic stake in Manning & Napier, signals a push to control both the origination and distribution of wealth and insurance solutions. While the stock has seen significant momentum, community discussion is currently polarized between those bullish on the company's record growth and platform scalability and those concerned by recent price volatility and technical trading pressures.

Satellogic, Inc. operates as a vertically integrated geospatial company. It is creating and continuously enhancing the first scalable, fully automated EO platform with the ability to remap the entire planet at both high-frequency and high-resolution, providing accessible and affordable solutions for customers. The company was founded by Emiliano Kargieman and Gerardo Richarte in July 2010 and is headquartered in Davidson, NC.

Satellogic Inc - Ordinary Shares - Class A

Satellogic is gaining momentum as the space sector heats up, fueled by anticipation surrounding potential SpaceX IPO news and active investment from major institutional players. The community remains focused on the company's operational milestones, including expansion into government defense contracts and the deployment of new satellite constellations, while keeping a close eye on technical breakouts and potential volatility.

Monad is a high-performance Layer 1 blockchain that processes 10,000 transactions per second with near-zero fees. The platform delivers high performance without compromising on security or decentralization, creating the infrastructure needed for complex applications that require high-frequency activity.  One of Monad’s key innovations lies in how it handles transaction processing. Instead of processing transactions one at a time like traditional blockchains, Monad processes multiple transactions simultaneously through parallel execution.   The system separates the agreement process from the execution process, allowing validators to first agree on which transactions to include and in what order, then having more time to execute those transactions without slowing down consensus. This approach, combined with a custom-built database called MonadDB, dramatically increases throughput while maintaining accuracy.  Monad also offers complete EVM compatibility, where applications built for Ethereum work on Monad without any code modifications, and users can connect with familiar wallets like MetaMask just as they would on Ethereum. Developers can immediately tap into Ethereum's established ecosystem of tools, libraries, and applications while benefitting from Monad’s performance improvements. The platform also runs on consumer-grade hardware rather than expensive specialized equipment, making it accessible for more people to participate in securing the network.  Monad has raised approximately 244 million dollars in total funding across multiple rounds. The company secured 19 million dollars in a seed round in February 2023 led by Dragonfly Capital, followed by a 225 million dollar Series A round in April 2024 led by Paradigm at a 3 billion dollar valuation. Other notable investors include Electric Capital, Greenoaks, Coinbase Ventures, and prominent angel investors such as Naval Ravikant.

Monad

Monad is capturing attention as community members debate its long-term potential as a high-performance Layer-1 blockchain, with active discussions focused on staking rewards and its technical advantages over existing protocols. Despite market volatility and investor concerns regarding token dilution, many remain bullish, viewing current price levels as an accumulation opportunity while awaiting further ecosystem catalysts and network growth.

BlackBerry Ltd. engages in the provision of intelligent security software and services. It operates through the following segments: Cybersecurity, Internet of Things (IoT), and Licensing and Other. The Cybersecurity segment includes the brand Cylance, BlackBerry Spark, AtHoc, and SecuSUITE. The IoT segment focuses on software licenses, support, maintenance, and professional services. The Licensing and Other segment involves the intellectual property licensing arrangements and settlement awards. The company was founded by Michael Lazaridis, James Laurence Balsillie, and Douglas E. Fregin on March 7, 1984 and is headquartered in Waterloo, Canada.

BlackBerry Ltd

BlackBerry is seeing increased community optimism as investors look toward the upcoming fiscal year 2027 guidance, with many highlighting the potential of the QNX division and its role in software-defined vehicles. The community remains focused on the company's ability to drive software-led revenue growth and is actively discussing recent partnerships with major automotive manufacturers as a foundational catalyst for future valuation.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Is Acurx Pharmaceuticals (ACXP) Stock Outpacing Its Medical Peers This Year?

Here is how Acurx Pharmaceuticals, Inc. (ACXP) and Apyx Medical (APYX) have performed compared to their sector so far this year.

Renuvion wins 2026 NewBeauty Award for "Best Minimally Invasive Skin Tightener"

Renuvion wins 2026 NewBeauty Award for 'Best Minimally Invasive Skin Tightener' Renuvion wins 2026 NewBeauty Award for 'Best Minimally Invasive Skin Tightener' PR Newswire CLEARWATER, Fla., April 1...

Tilray Brands' Q3 Earnings on the Horizon: What's in The Offing?

TLRY heads into Q3 FY26 earnings with projected revenues up 10.9% and narrower losses, but margin pressure in cannabis and beverages clouds the outlook.

Is Acurx Pharmaceuticals (ACXP) Outperforming Other Medical Stocks This Year?

Apyx Medical Corporation (NASDAQ:APYX) Short Interest Up 22.3% in February

Apyx Medical Corporation (NASDAQ:APYX - Get Free Report) was the recipient of a significant increase in short interest in February. As of February 27th, there was short interest totaling 173,573...

Apyx Medical Calls AYON a Game Changer at Citizens Conference, Targets Profitability in 2025

Apyx Medical (NASDAQ:APYX) executives used a conference discussion at the Citizens Life Sciences Conference to describe what CEO Charlie Goodwin called a fundamentally different company following the...

Apyx Medical (NASDAQ:APYX) Stock Price Expected to Rise, Craig Hallum Analyst Says

Craig Hallum upped their price target on Apyx Medical from $5.00 to $6.00 and gave the company a "buy" rating in a report on Wednesday...

Apyx Medical Corporation (NASDAQ:APYX) Given Average Rating of "Moderate Buy" by Brokerages

Apyx Medical Corporation (NASDAQ:APYX - Get Free Report) has earned a consensus rating of "Moderate Buy" from the five brokerages that are currently covering the firm, MarketBeat Ratings reports. One...

Apyx Medical (NASDAQ:APYX) Upgraded to Buy at BTIG Research

BTIG Research raised shares of Apyx Medical from a "neutral" rating to a "buy" rating and set a $6.00 price target on the stock in a research note on Wednesday...

This JM Smucker Analyst Turns Bullish; Here Are Top 4 Upgrades For Wednesday

Wall Street analysts upgraded Uniqure NV, Apyx Medical Inc, J M Smucker Co, and VTEX with raised price targets. See analyst ratings page.read more...

Apyx Medical Corp. operates as an energy-based medical technology company. The firm engages in developing, manufacturing, and marketing a range of electrosurgical products and technologies, as well as related medical products used by the offices of doctors, surgery centers, and hospitals worldwide. It operates through the following segments: Surgical Aesthetics and Original Equipment Manufacturer (OEM). The Surgical Aesthetics segment consists of the Helium Plasma Technology lines, which include Renuvion and J-Plasma. The OEM segment focuses on designing, development, and manufacturing electrosurgical equipment and medical devices by producing generators, medical devices and related accessories. The company was founded by Andrew Makrides in 1978 and is headquartered in Clearwater, FL.

Apyx Medical Corp

Opendoor ($OPEN)

Strategy ($MSTR)

American Eagle ($AEO)

Ondas Inc. ($ONDS)

The stock that proved the power of the crowd. Fueled by community energy and social momentum, this winner captivated retail investors regardless of what the "experts" or traditional fundamentals had to say.

APYX
Apyx Medical Corp

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest APYX News

APYXApyx Medical Corp